A reduced plasma ADAMTS13 activity and increased VWF levels are associated with an increased risk of cardiovascular and cerebrovascular diseases, such as atherosclerosis, stroke, and vascular remodeling [11–14]. Here, ADAMTS13 is linked to atherosclerosis.